Format

Send to

Choose Destination
See comment in PubMed Commons below
Am Heart J. 2015 Jul;170(1):164-72, 172.e1-5. doi: 10.1016/j.ahj.2015.04.018. Epub 2015 Apr 18.

Effect of access site, gender, and indication on clinical outcomes after percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society (BCIS).

Author information

1
Cardiovascular Research Group, Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom.
2
Farr Institute, University of Manchester, Manchester, United Kingdom.
3
Institute of Cellular Medicine, Newcastle University, Newcastle, United Kingdom.
4
Royal Stoke Hospital, University Hospital North Midlands, Stoke-on-Trent, United Kingdom.
5
Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom.
6
The James Cook University Hospital, Middlesbrough, United Kingdom.
7
Farr Institute, University of Manchester, Manchester, United Kingdom; Royal Stoke Hospital, University Hospital North Midlands, Stoke-on-Trent, United Kingdom; Cardiovascular Research Group, Institutes of Science and Technology in Medicine and Primary Care, Keele University, Staffordshire, United Kingdom. Electronic address: mamasmamas1@yahoo.co.uk.

Abstract

BACKGROUND:

Gender is a strong predictor of periprocedural major bleeding complications after percutaneous coronary intervention (PCI). The access site represents an important site of such bleeding complications, which has driven adoption of the transradial access (TRA) use during PCI, although female gender is an independent predictor of transradial PCI failure. This study sought to define gender differences in access site practice and study associations between access site choice and clinical outcomes for PCI over a 6-year period, through the analysis of the British Cardiovascular Intervention Society observational database.

METHODS AND RESULTS:

In-hospital major adverse cardiovascular events (a composite of in-hospital mortality and in-hospital myocardial reinfarction and target vessel revascularization), in-hospital bleeding complications, and 30-day mortality were studied based on gender and access site choice (transfemoral access, TRA) in 412,122 patients who underwent PCI between 2007 and 2012 in the United Kingdom. Use of TRA increased in both genders over time, although this lagged behind in women (21% in 2007 to 58% in 2012) compared with men (24% in 2007 to 64% in 2012). In both men and women, TRA was independently associated with a lower in-hospital major adverse cardiovascular event (odds ratio [OR] 0.82, 95% CI 0.76-0.90; OR 0.75, 95% CI 0.66-0.84), in-hospital major bleeding (OR 0.54, 95% CI 0.44-0.66; OR 0.26, 95% CI 0.20-0.33), and 30-day mortality (OR 0.80, 95% CI 0.73-0.89; OR 0.82, 95% CI 0.71-0.94), respectively.

CONCLUSIONS:

Where possible, TRA should be considered as the preferred access site choice for PCI, particularly in women in whom the greatest reductions bleeding end points were observed across all indications.

PMID:
26093878
DOI:
10.1016/j.ahj.2015.04.018
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center